Global Oral Thin Films

Oral Thin Films Comprehensive Study by Type (Oromucosal, Orodispersible, • Orally Disintegrating, • Orally Dissolving), Application (Allergy/Cough and Cold, Pain Management, Anti-flatulence, Neurological Disorders, Schizophrenia, Others), Distribution Channel (Direct, Indirect), End Use (Hospitals & Clinics, Medical Research Centres) Players and Region - Global Market Outlook to 2026

Oral Thin Films Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Oral Thin Films?
Oral thin films (OTFs) are polymeric films used to deliver therapeutics through oral administration. They are loaded with active substances like APIs. It is also administrated through gastrointestinal absorption. Oral thin films are known as a smart choice for drug delivery. It offers advantages like ease in administration and its patient friendly nature. They provide rapid movement of drug towards its targeted areas. It allows therapeutics to enter directly into the circulatory system by sublingual or oromucosal absorption. This direct absorption protects drugs from acidic stomachs conditions and hence large portion of API is able to move towards targeted area. This films are thin, flexible in nature which provides rapid delivery of drug. Thus, owing to this advantages, healthcare professionals prefers OFTs for rapid drug delivery. It is mostly prefers for geriatric population and children. Further it is used for wide range of disorders like chronic, & incidences of nausea and neurological diseases. Thus, significance associated with safe, efficient oral thin films is expected to drive the market growth over forecast period.

The market study is broken down by Type (Oromucosal, Orodispersible, • Orally Disintegrating and • Orally Dissolving), by Application (Allergy/Cough and Cold, Pain Management, Anti-flatulence, Neurological Disorders, Schizophrenia and Others) and major geographies with country level break-up.

The market of Oral Thin Film is expected to grow with rising demand from hospitals and research organisations. Rising number of chronic cases impacting on the demand in positive manner. Thus, various companies are operating in the market to provide excellent OTFs. Companies are involving in research & developments to providing OTFs with wide applicability. For instance, in 2019, Dr. Reddys Laboratories has launched generic version of indivior's Suboxone Sublingual Film which was previously launched by Mylan in United States. The market is highly fragmented owing to presence of major players. This market players are gaining attention owing to raised demand. However, new entries are focusing on providing upgraded versions of OTFs to the market. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Novartis AG (Switzerland), Cure Pharmaceutical (United States), AdhexPharma (France), Tapemark (United States), Avomee (United States), ARx, LLC. (United States), Umang Pharmaceuticals. (India), ODF Nutra inc. (Canada), XPhyto Therapeutics Corp. (Canada), ZIM Laboratories Limited (India), IntelGenx Corp. (United States), Seoul PharmaCo (South Korea) and Dr. Reddy’s Laboratories Ltd. (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Shilpa Therapeutics Pvt. Ltd (India) and Livkon Pharmaceutical Pvt Ltd (India).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Oral Thin Films market by Type, Application and Region.

On the basis of geography, the market of Oral Thin Films has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Direct will boost the Oral Thin Films market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End Use, the sub-segment i.e. Hospitals & Clinics will boost the Oral Thin Films market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

In October 2020, CURE Pharmaceutical Holding a subsidiary Sera Labs has launched the innovative OTFs called Nutri-Strips. Nutri-Strips allows rapid delivery by administrating directly on tongue. It is developed with advanced oral thin film strip technology RAD3. This RAD3 is mainly for quick Delivery of novel vitamins and supplements.
Patent- United States 10130684 B2- Filed In 2018 For Oral Dissolving Films For Insulin Administration, For Treating Diabetes and Patent- United States 9597287 B2- Filed In 2017 For Edible Oral Strip Or Wafer Dosage Form Containing On Exchange Resin For Taste Masking

Market Trend
  • Preference of Hospitals & Clinics for Patient Friendly OTFs for Children’s And Geriatric Population Has Been Grown

Market Drivers
  • Growing Expenditure of Healthcare Industry
  • Increasing Incidence of Neurological Disorders
  • Rising Geriatric Population

Opportunities
  • Government Funding’s to develop Novel Drug Delivery Systems
  • Simple Manufacturing Process & Continue Processing allows Cost Effective OTS Manufacturing which is Known as Lucrative Growth Opportunity for Market

Restraints
  • Limitations regarding Packaging & Dosing of OTFs may restrain its Demand
  • Straighten Regulatory Norms
  • Requirements of Massive Investments for R&D

Challenges
  • Huge Treatment Cost of Chronic Disorders in which OTFs are involved


Key Target Audience
Oral Thin Films Manufacturers/Suppliers/Distributor, Raw Material Suppliers, Research Centers, New Entrants/Investors, Strategic Business Planners, Governments and End Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Oromucosal
  • Orodispersible
  • • Orally Disintegrating
  • • Orally Dissolving
By Application
  • Allergy/Cough and Cold
  • Pain Management
  • Anti-flatulence
  • Neurological Disorders
  • Schizophrenia
  • Others
By Distribution Channel
  • Direct
  • Indirect

By End Use
  • Hospitals & Clinics
  • Medical Research Centres

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Expenditure of Healthcare Industry
      • 3.2.2. Increasing Incidence of Neurological Disorders
      • 3.2.3. Rising Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Huge Treatment Cost of Chronic Disorders in which OTFs are involved
    • 3.4. Market Trends
      • 3.4.1. Preference of Hospitals & Clinics for Patient Friendly OTFs for Children’s And Geriatric Population Has Been Grown
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Oral Thin Films, by Type, Application, Distribution Channel, End Use and Region (value and volume ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Oral Thin Films (Value)
      • 5.2.1. Global Oral Thin Films by: Type (Value)
        • 5.2.1.1. Oromucosal
        • 5.2.1.2. Orodispersible
        • 5.2.1.3. • Orally Disintegrating
        • 5.2.1.4. • Orally Dissolving
      • 5.2.2. Global Oral Thin Films by: Application (Value)
        • 5.2.2.1. Allergy/Cough and Cold
        • 5.2.2.2. Pain Management
        • 5.2.2.3. Anti-flatulence
        • 5.2.2.4. Neurological Disorders
        • 5.2.2.5. Schizophrenia
        • 5.2.2.6. Others
      • 5.2.3. Global Oral Thin Films by: Distribution Channel (Value)
        • 5.2.3.1. Direct
        • 5.2.3.2. Indirect
      • 5.2.4. Global Oral Thin Films by: End Use (Value)
        • 5.2.4.1. Hospitals & Clinics
        • 5.2.4.2. Medical Research Centres
      • 5.2.5. Global Oral Thin Films Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Oral Thin Films (Volume)
      • 5.3.1. Global Oral Thin Films by: Type (Volume)
        • 5.3.1.1. Oromucosal
        • 5.3.1.2. Orodispersible
        • 5.3.1.3. • Orally Disintegrating
        • 5.3.1.4. • Orally Dissolving
      • 5.3.2. Global Oral Thin Films by: Application (Volume)
        • 5.3.2.1. Allergy/Cough and Cold
        • 5.3.2.2. Pain Management
        • 5.3.2.3. Anti-flatulence
        • 5.3.2.4. Neurological Disorders
        • 5.3.2.5. Schizophrenia
        • 5.3.2.6. Others
      • 5.3.3. Global Oral Thin Films by: Distribution Channel (Volume)
        • 5.3.3.1. Direct
        • 5.3.3.2. Indirect
      • 5.3.4. Global Oral Thin Films by: End Use (Volume)
        • 5.3.4.1. Hospitals & Clinics
        • 5.3.4.2. Medical Research Centres
      • 5.3.5. Global Oral Thin Films Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
  • 6. Oral Thin Films: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Novartis AG (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cure Pharmaceutical (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. AdhexPharma (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Tapemark (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Avomee (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ARx, LLC. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Umang Pharmaceuticals. (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ODF Nutra inc. (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. XPhyto Therapeutics Corp. (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ZIM Laboratories Limited (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. IntelGenx Corp. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Seoul PharmaCo (South Korea)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Dr. Reddy’s Laboratories Ltd. (India)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Oral Thin Films Sale, by Type, Application, Distribution Channel, End Use and Region (value and volume ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Oral Thin Films (Value)
      • 7.2.1. Global Oral Thin Films by: Type (Value)
        • 7.2.1.1. Oromucosal
        • 7.2.1.2. Orodispersible
        • 7.2.1.3. • Orally Disintegrating
        • 7.2.1.4. • Orally Dissolving
      • 7.2.2. Global Oral Thin Films by: Application (Value)
        • 7.2.2.1. Allergy/Cough and Cold
        • 7.2.2.2. Pain Management
        • 7.2.2.3. Anti-flatulence
        • 7.2.2.4. Neurological Disorders
        • 7.2.2.5. Schizophrenia
        • 7.2.2.6. Others
      • 7.2.3. Global Oral Thin Films by: Distribution Channel (Value)
        • 7.2.3.1. Direct
        • 7.2.3.2. Indirect
      • 7.2.4. Global Oral Thin Films by: End Use (Value)
        • 7.2.4.1. Hospitals & Clinics
        • 7.2.4.2. Medical Research Centres
      • 7.2.5. Global Oral Thin Films Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Oral Thin Films (Volume)
      • 7.3.1. Global Oral Thin Films by: Type (Volume)
        • 7.3.1.1. Oromucosal
        • 7.3.1.2. Orodispersible
        • 7.3.1.3. • Orally Disintegrating
        • 7.3.1.4. • Orally Dissolving
      • 7.3.2. Global Oral Thin Films by: Application (Volume)
        • 7.3.2.1. Allergy/Cough and Cold
        • 7.3.2.2. Pain Management
        • 7.3.2.3. Anti-flatulence
        • 7.3.2.4. Neurological Disorders
        • 7.3.2.5. Schizophrenia
        • 7.3.2.6. Others
      • 7.3.3. Global Oral Thin Films by: Distribution Channel (Volume)
        • 7.3.3.1. Direct
        • 7.3.3.2. Indirect
      • 7.3.4. Global Oral Thin Films by: End Use (Volume)
        • 7.3.4.1. Hospitals & Clinics
        • 7.3.4.2. Medical Research Centres
      • 7.3.5. Global Oral Thin Films Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Oral Thin Films: by Type(USD Million)
  • Table 2. Oral Thin Films Oromucosal , by Region USD Million (2015-2020)
  • Table 3. Oral Thin Films Orodispersible , by Region USD Million (2015-2020)
  • Table 4. Oral Thin Films • Orally Disintegrating , by Region USD Million (2015-2020)
  • Table 5. Oral Thin Films • Orally Dissolving , by Region USD Million (2015-2020)
  • Table 6. Oral Thin Films: by Application(USD Million)
  • Table 7. Oral Thin Films Allergy/Cough and Cold , by Region USD Million (2015-2020)
  • Table 8. Oral Thin Films Pain Management , by Region USD Million (2015-2020)
  • Table 9. Oral Thin Films Anti-flatulence , by Region USD Million (2015-2020)
  • Table 10. Oral Thin Films Neurological Disorders , by Region USD Million (2015-2020)
  • Table 11. Oral Thin Films Schizophrenia , by Region USD Million (2015-2020)
  • Table 12. Oral Thin Films Others , by Region USD Million (2015-2020)
  • Table 13. Oral Thin Films: by Distribution Channel(USD Million)
  • Table 14. Oral Thin Films Direct , by Region USD Million (2015-2020)
  • Table 15. Oral Thin Films Indirect , by Region USD Million (2015-2020)
  • Table 16. Oral Thin Films: by End Use(USD Million)
  • Table 17. Oral Thin Films Hospitals & Clinics , by Region USD Million (2015-2020)
  • Table 18. Oral Thin Films Medical Research Centres , by Region USD Million (2015-2020)
  • Table 19. South America Oral Thin Films, by Country USD Million (2015-2020)
  • Table 20. South America Oral Thin Films, by Type USD Million (2015-2020)
  • Table 21. South America Oral Thin Films, by Application USD Million (2015-2020)
  • Table 22. South America Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 23. South America Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 24. Brazil Oral Thin Films, by Type USD Million (2015-2020)
  • Table 25. Brazil Oral Thin Films, by Application USD Million (2015-2020)
  • Table 26. Brazil Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 27. Brazil Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 28. Argentina Oral Thin Films, by Type USD Million (2015-2020)
  • Table 29. Argentina Oral Thin Films, by Application USD Million (2015-2020)
  • Table 30. Argentina Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 31. Argentina Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 32. Rest of South America Oral Thin Films, by Type USD Million (2015-2020)
  • Table 33. Rest of South America Oral Thin Films, by Application USD Million (2015-2020)
  • Table 34. Rest of South America Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 35. Rest of South America Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 36. Asia Pacific Oral Thin Films, by Country USD Million (2015-2020)
  • Table 37. Asia Pacific Oral Thin Films, by Type USD Million (2015-2020)
  • Table 38. Asia Pacific Oral Thin Films, by Application USD Million (2015-2020)
  • Table 39. Asia Pacific Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 40. Asia Pacific Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 41. China Oral Thin Films, by Type USD Million (2015-2020)
  • Table 42. China Oral Thin Films, by Application USD Million (2015-2020)
  • Table 43. China Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 44. China Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 45. Japan Oral Thin Films, by Type USD Million (2015-2020)
  • Table 46. Japan Oral Thin Films, by Application USD Million (2015-2020)
  • Table 47. Japan Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 48. Japan Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 49. India Oral Thin Films, by Type USD Million (2015-2020)
  • Table 50. India Oral Thin Films, by Application USD Million (2015-2020)
  • Table 51. India Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 52. India Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 53. South Korea Oral Thin Films, by Type USD Million (2015-2020)
  • Table 54. South Korea Oral Thin Films, by Application USD Million (2015-2020)
  • Table 55. South Korea Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 56. South Korea Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 57. Taiwan Oral Thin Films, by Type USD Million (2015-2020)
  • Table 58. Taiwan Oral Thin Films, by Application USD Million (2015-2020)
  • Table 59. Taiwan Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 60. Taiwan Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 61. Australia Oral Thin Films, by Type USD Million (2015-2020)
  • Table 62. Australia Oral Thin Films, by Application USD Million (2015-2020)
  • Table 63. Australia Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 64. Australia Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Oral Thin Films, by Type USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Oral Thin Films, by Application USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 69. Europe Oral Thin Films, by Country USD Million (2015-2020)
  • Table 70. Europe Oral Thin Films, by Type USD Million (2015-2020)
  • Table 71. Europe Oral Thin Films, by Application USD Million (2015-2020)
  • Table 72. Europe Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 73. Europe Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 74. Germany Oral Thin Films, by Type USD Million (2015-2020)
  • Table 75. Germany Oral Thin Films, by Application USD Million (2015-2020)
  • Table 76. Germany Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 77. Germany Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 78. France Oral Thin Films, by Type USD Million (2015-2020)
  • Table 79. France Oral Thin Films, by Application USD Million (2015-2020)
  • Table 80. France Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 81. France Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 82. Italy Oral Thin Films, by Type USD Million (2015-2020)
  • Table 83. Italy Oral Thin Films, by Application USD Million (2015-2020)
  • Table 84. Italy Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 85. Italy Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 86. United Kingdom Oral Thin Films, by Type USD Million (2015-2020)
  • Table 87. United Kingdom Oral Thin Films, by Application USD Million (2015-2020)
  • Table 88. United Kingdom Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 89. United Kingdom Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 90. Netherlands Oral Thin Films, by Type USD Million (2015-2020)
  • Table 91. Netherlands Oral Thin Films, by Application USD Million (2015-2020)
  • Table 92. Netherlands Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 93. Netherlands Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 94. Rest of Europe Oral Thin Films, by Type USD Million (2015-2020)
  • Table 95. Rest of Europe Oral Thin Films, by Application USD Million (2015-2020)
  • Table 96. Rest of Europe Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 97. Rest of Europe Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 98. MEA Oral Thin Films, by Country USD Million (2015-2020)
  • Table 99. MEA Oral Thin Films, by Type USD Million (2015-2020)
  • Table 100. MEA Oral Thin Films, by Application USD Million (2015-2020)
  • Table 101. MEA Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 102. MEA Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 103. Middle East Oral Thin Films, by Type USD Million (2015-2020)
  • Table 104. Middle East Oral Thin Films, by Application USD Million (2015-2020)
  • Table 105. Middle East Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 106. Middle East Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 107. Africa Oral Thin Films, by Type USD Million (2015-2020)
  • Table 108. Africa Oral Thin Films, by Application USD Million (2015-2020)
  • Table 109. Africa Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 110. Africa Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 111. North America Oral Thin Films, by Country USD Million (2015-2020)
  • Table 112. North America Oral Thin Films, by Type USD Million (2015-2020)
  • Table 113. North America Oral Thin Films, by Application USD Million (2015-2020)
  • Table 114. North America Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 115. North America Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 116. United States Oral Thin Films, by Type USD Million (2015-2020)
  • Table 117. United States Oral Thin Films, by Application USD Million (2015-2020)
  • Table 118. United States Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 119. United States Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 120. Canada Oral Thin Films, by Type USD Million (2015-2020)
  • Table 121. Canada Oral Thin Films, by Application USD Million (2015-2020)
  • Table 122. Canada Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 123. Canada Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 124. Mexico Oral Thin Films, by Type USD Million (2015-2020)
  • Table 125. Mexico Oral Thin Films, by Application USD Million (2015-2020)
  • Table 126. Mexico Oral Thin Films, by Distribution Channel USD Million (2015-2020)
  • Table 127. Mexico Oral Thin Films, by End Use USD Million (2015-2020)
  • Table 128. Oral Thin Films Sales: by Type(K Tons)
  • Table 129. Oral Thin Films Sales Oromucosal , by Region K Tons (2015-2020)
  • Table 130. Oral Thin Films Sales Orodispersible , by Region K Tons (2015-2020)
  • Table 131. Oral Thin Films Sales • Orally Disintegrating , by Region K Tons (2015-2020)
  • Table 132. Oral Thin Films Sales • Orally Dissolving , by Region K Tons (2015-2020)
  • Table 133. Oral Thin Films Sales: by Application(K Tons)
  • Table 134. Oral Thin Films Sales Allergy/Cough and Cold , by Region K Tons (2015-2020)
  • Table 135. Oral Thin Films Sales Pain Management , by Region K Tons (2015-2020)
  • Table 136. Oral Thin Films Sales Anti-flatulence , by Region K Tons (2015-2020)
  • Table 137. Oral Thin Films Sales Neurological Disorders , by Region K Tons (2015-2020)
  • Table 138. Oral Thin Films Sales Schizophrenia , by Region K Tons (2015-2020)
  • Table 139. Oral Thin Films Sales Others , by Region K Tons (2015-2020)
  • Table 140. Oral Thin Films Sales: by Distribution Channel(K Tons)
  • Table 141. Oral Thin Films Sales Direct , by Region K Tons (2015-2020)
  • Table 142. Oral Thin Films Sales Indirect , by Region K Tons (2015-2020)
  • Table 143. Oral Thin Films Sales: by End Use(K Tons)
  • Table 144. Oral Thin Films Sales Hospitals & Clinics , by Region K Tons (2015-2020)
  • Table 145. Oral Thin Films Sales Medical Research Centres , by Region K Tons (2015-2020)
  • Table 146. South America Oral Thin Films Sales, by Country K Tons (2015-2020)
  • Table 147. South America Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 148. South America Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 149. South America Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 150. South America Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 151. Brazil Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 152. Brazil Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 153. Brazil Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 154. Brazil Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 155. Argentina Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 156. Argentina Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 157. Argentina Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 158. Argentina Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 159. Rest of South America Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 160. Rest of South America Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 161. Rest of South America Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 162. Rest of South America Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 163. Asia Pacific Oral Thin Films Sales, by Country K Tons (2015-2020)
  • Table 164. Asia Pacific Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 165. Asia Pacific Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 166. Asia Pacific Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 167. Asia Pacific Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 168. China Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 169. China Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 170. China Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 171. China Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 172. Japan Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 173. Japan Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 174. Japan Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 175. Japan Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 176. India Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 177. India Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 178. India Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 179. India Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 180. South Korea Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 181. South Korea Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 182. South Korea Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 183. South Korea Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 184. Taiwan Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 185. Taiwan Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 186. Taiwan Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 187. Taiwan Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 188. Australia Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 189. Australia Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 190. Australia Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 191. Australia Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 192. Rest of Asia-Pacific Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 193. Rest of Asia-Pacific Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 194. Rest of Asia-Pacific Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 195. Rest of Asia-Pacific Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 196. Europe Oral Thin Films Sales, by Country K Tons (2015-2020)
  • Table 197. Europe Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 198. Europe Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 199. Europe Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 200. Europe Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 201. Germany Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 202. Germany Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 203. Germany Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 204. Germany Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 205. France Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 206. France Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 207. France Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 208. France Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 209. Italy Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 210. Italy Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 211. Italy Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 212. Italy Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 213. United Kingdom Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 214. United Kingdom Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 215. United Kingdom Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 216. United Kingdom Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 217. Netherlands Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 218. Netherlands Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 219. Netherlands Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 220. Netherlands Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 221. Rest of Europe Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 222. Rest of Europe Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 223. Rest of Europe Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 224. Rest of Europe Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 225. MEA Oral Thin Films Sales, by Country K Tons (2015-2020)
  • Table 226. MEA Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 227. MEA Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 228. MEA Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 229. MEA Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 230. Middle East Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 231. Middle East Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 232. Middle East Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 233. Middle East Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 234. Africa Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 235. Africa Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 236. Africa Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 237. Africa Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 238. North America Oral Thin Films Sales, by Country K Tons (2015-2020)
  • Table 239. North America Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 240. North America Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 241. North America Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 242. North America Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 243. United States Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 244. United States Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 245. United States Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 246. United States Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 247. Canada Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 248. Canada Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 249. Canada Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 250. Canada Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 251. Mexico Oral Thin Films Sales, by Type K Tons (2015-2020)
  • Table 252. Mexico Oral Thin Films Sales, by Application K Tons (2015-2020)
  • Table 253. Mexico Oral Thin Films Sales, by Distribution Channel K Tons (2015-2020)
  • Table 254. Mexico Oral Thin Films Sales, by End Use K Tons (2015-2020)
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Oral Thin Films: by Type(USD Million)
  • Table 269. Oral Thin Films Oromucosal , by Region USD Million (2021-2026)
  • Table 270. Oral Thin Films Orodispersible , by Region USD Million (2021-2026)
  • Table 271. Oral Thin Films • Orally Disintegrating , by Region USD Million (2021-2026)
  • Table 272. Oral Thin Films • Orally Dissolving , by Region USD Million (2021-2026)
  • Table 273. Oral Thin Films: by Application(USD Million)
  • Table 274. Oral Thin Films Allergy/Cough and Cold , by Region USD Million (2021-2026)
  • Table 275. Oral Thin Films Pain Management , by Region USD Million (2021-2026)
  • Table 276. Oral Thin Films Anti-flatulence , by Region USD Million (2021-2026)
  • Table 277. Oral Thin Films Neurological Disorders , by Region USD Million (2021-2026)
  • Table 278. Oral Thin Films Schizophrenia , by Region USD Million (2021-2026)
  • Table 279. Oral Thin Films Others , by Region USD Million (2021-2026)
  • Table 280. Oral Thin Films: by Distribution Channel(USD Million)
  • Table 281. Oral Thin Films Direct , by Region USD Million (2021-2026)
  • Table 282. Oral Thin Films Indirect , by Region USD Million (2021-2026)
  • Table 283. Oral Thin Films: by End Use(USD Million)
  • Table 284. Oral Thin Films Hospitals & Clinics , by Region USD Million (2021-2026)
  • Table 285. Oral Thin Films Medical Research Centres , by Region USD Million (2021-2026)
  • Table 286. South America Oral Thin Films, by Country USD Million (2021-2026)
  • Table 287. South America Oral Thin Films, by Type USD Million (2021-2026)
  • Table 288. South America Oral Thin Films, by Application USD Million (2021-2026)
  • Table 289. South America Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 290. South America Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 291. Brazil Oral Thin Films, by Type USD Million (2021-2026)
  • Table 292. Brazil Oral Thin Films, by Application USD Million (2021-2026)
  • Table 293. Brazil Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 294. Brazil Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 295. Argentina Oral Thin Films, by Type USD Million (2021-2026)
  • Table 296. Argentina Oral Thin Films, by Application USD Million (2021-2026)
  • Table 297. Argentina Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 298. Argentina Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 299. Rest of South America Oral Thin Films, by Type USD Million (2021-2026)
  • Table 300. Rest of South America Oral Thin Films, by Application USD Million (2021-2026)
  • Table 301. Rest of South America Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 302. Rest of South America Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 303. Asia Pacific Oral Thin Films, by Country USD Million (2021-2026)
  • Table 304. Asia Pacific Oral Thin Films, by Type USD Million (2021-2026)
  • Table 305. Asia Pacific Oral Thin Films, by Application USD Million (2021-2026)
  • Table 306. Asia Pacific Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 307. Asia Pacific Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 308. China Oral Thin Films, by Type USD Million (2021-2026)
  • Table 309. China Oral Thin Films, by Application USD Million (2021-2026)
  • Table 310. China Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 311. China Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 312. Japan Oral Thin Films, by Type USD Million (2021-2026)
  • Table 313. Japan Oral Thin Films, by Application USD Million (2021-2026)
  • Table 314. Japan Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 315. Japan Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 316. India Oral Thin Films, by Type USD Million (2021-2026)
  • Table 317. India Oral Thin Films, by Application USD Million (2021-2026)
  • Table 318. India Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 319. India Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 320. South Korea Oral Thin Films, by Type USD Million (2021-2026)
  • Table 321. South Korea Oral Thin Films, by Application USD Million (2021-2026)
  • Table 322. South Korea Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 323. South Korea Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 324. Taiwan Oral Thin Films, by Type USD Million (2021-2026)
  • Table 325. Taiwan Oral Thin Films, by Application USD Million (2021-2026)
  • Table 326. Taiwan Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 327. Taiwan Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 328. Australia Oral Thin Films, by Type USD Million (2021-2026)
  • Table 329. Australia Oral Thin Films, by Application USD Million (2021-2026)
  • Table 330. Australia Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 331. Australia Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 332. Rest of Asia-Pacific Oral Thin Films, by Type USD Million (2021-2026)
  • Table 333. Rest of Asia-Pacific Oral Thin Films, by Application USD Million (2021-2026)
  • Table 334. Rest of Asia-Pacific Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 335. Rest of Asia-Pacific Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 336. Europe Oral Thin Films, by Country USD Million (2021-2026)
  • Table 337. Europe Oral Thin Films, by Type USD Million (2021-2026)
  • Table 338. Europe Oral Thin Films, by Application USD Million (2021-2026)
  • Table 339. Europe Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 340. Europe Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 341. Germany Oral Thin Films, by Type USD Million (2021-2026)
  • Table 342. Germany Oral Thin Films, by Application USD Million (2021-2026)
  • Table 343. Germany Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 344. Germany Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 345. France Oral Thin Films, by Type USD Million (2021-2026)
  • Table 346. France Oral Thin Films, by Application USD Million (2021-2026)
  • Table 347. France Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 348. France Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 349. Italy Oral Thin Films, by Type USD Million (2021-2026)
  • Table 350. Italy Oral Thin Films, by Application USD Million (2021-2026)
  • Table 351. Italy Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 352. Italy Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 353. United Kingdom Oral Thin Films, by Type USD Million (2021-2026)
  • Table 354. United Kingdom Oral Thin Films, by Application USD Million (2021-2026)
  • Table 355. United Kingdom Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 356. United Kingdom Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 357. Netherlands Oral Thin Films, by Type USD Million (2021-2026)
  • Table 358. Netherlands Oral Thin Films, by Application USD Million (2021-2026)
  • Table 359. Netherlands Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 360. Netherlands Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 361. Rest of Europe Oral Thin Films, by Type USD Million (2021-2026)
  • Table 362. Rest of Europe Oral Thin Films, by Application USD Million (2021-2026)
  • Table 363. Rest of Europe Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 364. Rest of Europe Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 365. MEA Oral Thin Films, by Country USD Million (2021-2026)
  • Table 366. MEA Oral Thin Films, by Type USD Million (2021-2026)
  • Table 367. MEA Oral Thin Films, by Application USD Million (2021-2026)
  • Table 368. MEA Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 369. MEA Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 370. Middle East Oral Thin Films, by Type USD Million (2021-2026)
  • Table 371. Middle East Oral Thin Films, by Application USD Million (2021-2026)
  • Table 372. Middle East Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 373. Middle East Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 374. Africa Oral Thin Films, by Type USD Million (2021-2026)
  • Table 375. Africa Oral Thin Films, by Application USD Million (2021-2026)
  • Table 376. Africa Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 377. Africa Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 378. North America Oral Thin Films, by Country USD Million (2021-2026)
  • Table 379. North America Oral Thin Films, by Type USD Million (2021-2026)
  • Table 380. North America Oral Thin Films, by Application USD Million (2021-2026)
  • Table 381. North America Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 382. North America Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 383. United States Oral Thin Films, by Type USD Million (2021-2026)
  • Table 384. United States Oral Thin Films, by Application USD Million (2021-2026)
  • Table 385. United States Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 386. United States Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 387. Canada Oral Thin Films, by Type USD Million (2021-2026)
  • Table 388. Canada Oral Thin Films, by Application USD Million (2021-2026)
  • Table 389. Canada Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 390. Canada Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 391. Mexico Oral Thin Films, by Type USD Million (2021-2026)
  • Table 392. Mexico Oral Thin Films, by Application USD Million (2021-2026)
  • Table 393. Mexico Oral Thin Films, by Distribution Channel USD Million (2021-2026)
  • Table 394. Mexico Oral Thin Films, by End Use USD Million (2021-2026)
  • Table 395. Oral Thin Films Sales: by Type(K Tons)
  • Table 396. Oral Thin Films Sales Oromucosal , by Region K Tons (2021-2026)
  • Table 397. Oral Thin Films Sales Orodispersible , by Region K Tons (2021-2026)
  • Table 398. Oral Thin Films Sales • Orally Disintegrating , by Region K Tons (2021-2026)
  • Table 399. Oral Thin Films Sales • Orally Dissolving , by Region K Tons (2021-2026)
  • Table 400. Oral Thin Films Sales: by Application(K Tons)
  • Table 401. Oral Thin Films Sales Allergy/Cough and Cold , by Region K Tons (2021-2026)
  • Table 402. Oral Thin Films Sales Pain Management , by Region K Tons (2021-2026)
  • Table 403. Oral Thin Films Sales Anti-flatulence , by Region K Tons (2021-2026)
  • Table 404. Oral Thin Films Sales Neurological Disorders , by Region K Tons (2021-2026)
  • Table 405. Oral Thin Films Sales Schizophrenia , by Region K Tons (2021-2026)
  • Table 406. Oral Thin Films Sales Others , by Region K Tons (2021-2026)
  • Table 407. Oral Thin Films Sales: by Distribution Channel(K Tons)
  • Table 408. Oral Thin Films Sales Direct , by Region K Tons (2021-2026)
  • Table 409. Oral Thin Films Sales Indirect , by Region K Tons (2021-2026)
  • Table 410. Oral Thin Films Sales: by End Use(K Tons)
  • Table 411. Oral Thin Films Sales Hospitals & Clinics , by Region K Tons (2021-2026)
  • Table 412. Oral Thin Films Sales Medical Research Centres , by Region K Tons (2021-2026)
  • Table 413. South America Oral Thin Films Sales, by Country K Tons (2021-2026)
  • Table 414. South America Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 415. South America Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 416. South America Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 417. South America Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 418. Brazil Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 419. Brazil Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 420. Brazil Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 421. Brazil Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 422. Argentina Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 423. Argentina Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 424. Argentina Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 425. Argentina Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 426. Rest of South America Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 427. Rest of South America Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 428. Rest of South America Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 429. Rest of South America Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 430. Asia Pacific Oral Thin Films Sales, by Country K Tons (2021-2026)
  • Table 431. Asia Pacific Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 432. Asia Pacific Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 433. Asia Pacific Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 434. Asia Pacific Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 435. China Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 436. China Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 437. China Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 438. China Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 439. Japan Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 440. Japan Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 441. Japan Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 442. Japan Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 443. India Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 444. India Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 445. India Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 446. India Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 447. South Korea Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 448. South Korea Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 449. South Korea Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 450. South Korea Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 451. Taiwan Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 452. Taiwan Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 453. Taiwan Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 454. Taiwan Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 455. Australia Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 456. Australia Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 457. Australia Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 458. Australia Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 459. Rest of Asia-Pacific Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 460. Rest of Asia-Pacific Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 461. Rest of Asia-Pacific Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 462. Rest of Asia-Pacific Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 463. Europe Oral Thin Films Sales, by Country K Tons (2021-2026)
  • Table 464. Europe Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 465. Europe Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 466. Europe Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 467. Europe Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 468. Germany Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 469. Germany Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 470. Germany Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 471. Germany Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 472. France Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 473. France Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 474. France Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 475. France Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 476. Italy Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 477. Italy Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 478. Italy Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 479. Italy Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 480. United Kingdom Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 481. United Kingdom Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 482. United Kingdom Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 483. United Kingdom Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 484. Netherlands Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 485. Netherlands Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 486. Netherlands Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 487. Netherlands Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 488. Rest of Europe Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 489. Rest of Europe Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 490. Rest of Europe Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 491. Rest of Europe Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 492. MEA Oral Thin Films Sales, by Country K Tons (2021-2026)
  • Table 493. MEA Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 494. MEA Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 495. MEA Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 496. MEA Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 497. Middle East Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 498. Middle East Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 499. Middle East Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 500. Middle East Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 501. Africa Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 502. Africa Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 503. Africa Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 504. Africa Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 505. North America Oral Thin Films Sales, by Country K Tons (2021-2026)
  • Table 506. North America Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 507. North America Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 508. North America Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 509. North America Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 510. United States Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 511. United States Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 512. United States Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 513. United States Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 514. Canada Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 515. Canada Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 516. Canada Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 517. Canada Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 518. Mexico Oral Thin Films Sales, by Type K Tons (2021-2026)
  • Table 519. Mexico Oral Thin Films Sales, by Application K Tons (2021-2026)
  • Table 520. Mexico Oral Thin Films Sales, by Distribution Channel K Tons (2021-2026)
  • Table 521. Mexico Oral Thin Films Sales, by End Use K Tons (2021-2026)
  • Table 522. Research Programs/Design for This Report
  • Table 523. Key Data Information from Secondary Sources
  • Table 524. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Oral Thin Films: by Type USD Million (2015-2020)
  • Figure 5. Global Oral Thin Films: by Application USD Million (2015-2020)
  • Figure 6. Global Oral Thin Films: by Distribution Channel USD Million (2015-2020)
  • Figure 7. Global Oral Thin Films: by End Use USD Million (2015-2020)
  • Figure 8. South America Oral Thin Films Share (%), by Country
  • Figure 9. Asia Pacific Oral Thin Films Share (%), by Country
  • Figure 10. Europe Oral Thin Films Share (%), by Country
  • Figure 11. MEA Oral Thin Films Share (%), by Country
  • Figure 12. North America Oral Thin Films Share (%), by Country
  • Figure 13. Global Oral Thin Films: by Type K Tons (2015-2020)
  • Figure 14. Global Oral Thin Films: by Application K Tons (2015-2020)
  • Figure 15. Global Oral Thin Films: by Distribution Channel K Tons (2015-2020)
  • Figure 16. Global Oral Thin Films: by End Use K Tons (2015-2020)
  • Figure 17. South America Oral Thin Films Share (%), by Country
  • Figure 18. Asia Pacific Oral Thin Films Share (%), by Country
  • Figure 19. Europe Oral Thin Films Share (%), by Country
  • Figure 20. MEA Oral Thin Films Share (%), by Country
  • Figure 21. North America Oral Thin Films Share (%), by Country
  • Figure 22. Global Oral Thin Films share by Players 2020 (%)
  • Figure 23. Global Oral Thin Films share by Players (Top 3) 2020(%)
  • Figure 24. Global Oral Thin Films share by Players (Top 5) 2020(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 27. Novartis AG (Switzerland) Revenue: by Geography 2020
  • Figure 28. Cure Pharmaceutical (United States) Revenue, Net Income and Gross profit
  • Figure 29. Cure Pharmaceutical (United States) Revenue: by Geography 2020
  • Figure 30. AdhexPharma (France) Revenue, Net Income and Gross profit
  • Figure 31. AdhexPharma (France) Revenue: by Geography 2020
  • Figure 32. Tapemark (United States) Revenue, Net Income and Gross profit
  • Figure 33. Tapemark (United States) Revenue: by Geography 2020
  • Figure 34. Avomee (United States) Revenue, Net Income and Gross profit
  • Figure 35. Avomee (United States) Revenue: by Geography 2020
  • Figure 36. ARx, LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 37. ARx, LLC. (United States) Revenue: by Geography 2020
  • Figure 38. Umang Pharmaceuticals. (India) Revenue, Net Income and Gross profit
  • Figure 39. Umang Pharmaceuticals. (India) Revenue: by Geography 2020
  • Figure 40. ODF Nutra inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 41. ODF Nutra inc. (Canada) Revenue: by Geography 2020
  • Figure 42. XPhyto Therapeutics Corp. (Canada) Revenue, Net Income and Gross profit
  • Figure 43. XPhyto Therapeutics Corp. (Canada) Revenue: by Geography 2020
  • Figure 44. ZIM Laboratories Limited (India) Revenue, Net Income and Gross profit
  • Figure 45. ZIM Laboratories Limited (India) Revenue: by Geography 2020
  • Figure 46. IntelGenx Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 47. IntelGenx Corp. (United States) Revenue: by Geography 2020
  • Figure 48. Seoul PharmaCo (South Korea) Revenue, Net Income and Gross profit
  • Figure 49. Seoul PharmaCo (South Korea) Revenue: by Geography 2020
  • Figure 50. Dr. Reddy’s Laboratories Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 51. Dr. Reddy’s Laboratories Ltd. (India) Revenue: by Geography 2020
  • Figure 52. Global Oral Thin Films: by Type USD Million (2021-2026)
  • Figure 53. Global Oral Thin Films: by Application USD Million (2021-2026)
  • Figure 54. Global Oral Thin Films: by Distribution Channel USD Million (2021-2026)
  • Figure 55. Global Oral Thin Films: by End Use USD Million (2021-2026)
  • Figure 56. South America Oral Thin Films Share (%), by Country
  • Figure 57. Asia Pacific Oral Thin Films Share (%), by Country
  • Figure 58. Europe Oral Thin Films Share (%), by Country
  • Figure 59. MEA Oral Thin Films Share (%), by Country
  • Figure 60. North America Oral Thin Films Share (%), by Country
  • Figure 61. Global Oral Thin Films: by Type K Tons (2021-2026)
  • Figure 62. Global Oral Thin Films: by Application K Tons (2021-2026)
  • Figure 63. Global Oral Thin Films: by Distribution Channel K Tons (2021-2026)
  • Figure 64. Global Oral Thin Films: by End Use K Tons (2021-2026)
  • Figure 65. South America Oral Thin Films Share (%), by Country
  • Figure 66. Asia Pacific Oral Thin Films Share (%), by Country
  • Figure 67. Europe Oral Thin Films Share (%), by Country
  • Figure 68. MEA Oral Thin Films Share (%), by Country
  • Figure 69. North America Oral Thin Films Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Novartis AG (Switzerland)
  • Cure Pharmaceutical (United States)
  • AdhexPharma (France)
  • Tapemark (United States)
  • Avomee (United States)
  • ARx, LLC. (United States)
  • Umang Pharmaceuticals. (India)
  • ODF Nutra inc. (Canada)
  • XPhyto Therapeutics Corp. (Canada)
  • ZIM Laboratories Limited (India)
  • IntelGenx Corp. (United States)
  • Seoul PharmaCo (South Korea)
  • Dr. Reddy’s Laboratories Ltd. (India)
Additional players considered in the study are as follows:
Shilpa Therapeutics Pvt. Ltd (India) , Livkon Pharmaceutical Pvt Ltd (India) ,
Select User Access Type

Key Highlights of Report


Apr 2021 217 Pages 95 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Oral Thin Films Quantitative research analysis
Global Oral Thin Films Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Novartis AG (Switzerland), Cure Pharmaceutical (United States), AdhexPharma (France), Tapemark (United States), Avomee (United States), ARx, LLC. (United States), Umang Pharmaceuticals. (India), ODF Nutra inc. (Canada), XPhyto Therapeutics Corp. (Canada), ZIM Laboratories Limited (India), IntelGenx Corp. (United States), Seoul PharmaCo (South Korea) and Dr. Reddy’s Laboratories Ltd. (India) etc.
Analysts at AMA estimates Oral Thin Films Market to reach USDXXX by 2026.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Oral Thin Films Report?

Have a Query? Click Here

Other Related Reports

Animal Nutrition Comprehensive Study by Type (Minerals, Amino Acids, Vitamins, Enzymes, Others), Application (Poultry Feeds, Ruminant Feeds, Pig Feeds, Aquaculture Feeds, Others), Form (Dry, Liquid) ...
$ 3500
Compounding Pharmacies Comprehensive Study by Type (Oral Medication (Capsules, Tablets, Suspensions, Lozenges, and Others), Topical Medication (Creams, Gels, Ointments, and Others), Mouthwashes, Supp...
$ 3750
Vitamin B3 Comprehensive Study by Type (Pharmaceutical Grade, Feed Grade), Application (Feed Additives, Food and Drinks Industry, Pharmaceutical Industry, Daily Chemicals) Players and Region - Global...
$ 3500
Pharmaceutical & Biotechnology Environmental Monitoring Comprehensive Study by Type (Monitoring Equipment (Particle Counters, Air Samplers, Temperature/ Humidity Monitors, Microbial Identification Sy...
$ 3350
Allergy Medicine Comprehensive Study by Type (Tablet, Liquid), Allergy (Drug Allergy, Food Allergy, Skin Allergy, Insect Allergy, Latex Allergy, Others), Symptoms (Hives, Fever) Players and Region -...
$ 3500
Metronidazole Comprehensive Study by Type (Metronidazole Tablets, Metronidazole Capsule, Metronidazole Injection, Others), Application (Anaerobic Bacterial Infections, Sexually Transmitted Disease, B...
$ 3750